Stay updated with breaking news from Matt Phipps. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.
When it comes to life, love, and relationships, Poh Ling Yeow has a more progressive approach than most and is friends with her ex-husbands.
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackBuffett Praises Apple After Trimming It, Drops Paramount StakeTreasury Rally Risks Running Into a $125 Billion Brick WallFrance’s Macron Calls for Reset of Economic Ties With ChinaLamborghini Bros No More: Crypto Is Creating a New Wealth EffectThe shares
Amgen’s update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.
Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.